Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.
You can purchase shares of Emergent BioSolutions (NYSE:EBS) through any online brokerage.
Other companies in Emergent BioSolutions’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Larimar Therapeutics (NASDAQ:LRMR).
Emergent BioSolutions has a consensus price target of $27.00.
The stock price for Emergent BioSolutions (NYSE: EBS) is $9.26 last updated October 22, 2024 at 4:37 PM EDT.
There are no upcoming dividends for Emergent BioSolutions.
Emergent BioSolutions’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Emergent BioSolutions.
Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.